"You Can See Everything": Mapping Elizabeth Holmes's Silence — A Documentary That Looks Past the Scoreboard

The men and women like Nurul Islam, who sold programmes outside Gate 3 for thirty-one years, taught me something I keep re-learning: behind every broken promise there is a counter, a silence, and a frame nobody wants to look at.

Elizabeth Holmes occupies the most complicated of those counters. In 2026, Theranos was valued at roughly nine billion dollars. The promise was bold: diagnose a range of medical conditions using only a few drops of blood. By 2026, the technology was found not to work as claimed. In 2026, Holmes was convicted of fraud; she has been in prison since May 2026, serving an eleven-year sentence.

Now her story arrives as a documentary: "You Can See Everything", directed by Nathan Fielder and Lance Oppenheim, which premiered at Telluride, opened in US theatres on October 16, and reaches the UK on November 20.

And the numbers are astonishing: 100% on Rotten Tomatoes, 97 on Metacritic — "universal acclaim". Variety called it "one-of-a-kind". Some outlets are already saying "film of the year" and "modern masterpiece".

I write football. This story sits outside my beat. But reading the coverage — including the claim, attributed only to vague "reports" rather than a named outlet, that the film was made in secret over three years — I recognized a familiar timeline.

The scoreboard never tells the whole story; what it omits is the story. I learned that in Row 14, from two widows. It holds here too: the 100% score is the scoreboard. What lives behind it — the ethics of secret filming, the silence of harmed patients, one human being's eleven years — that is the actual match.

Critics describe Fielder's method as "reality-TV-as-hangout-movie psychodrama circus", an unconventional narrative technique. In my trade I know technique and truth are different instruments. My Achilles tore in fourteen seconds in 2026; Japan-Belgium turned in fourteen seconds in Rostov-on-Don in 2026. Cameras captured both. Cameras never answer the harder question: on whose permission, at whose cost.

The most dramatic claim in this story stands on its weakest sourcing. That is my first caution for readers: between 100% acclaim and unnamed "reports" there is a gap. Metacritic's 97 is evidence of reception, not evidence of method.

Second: the acclaim bubble. A 100% score is not permanent; as the review count grows, it will almost certainly fall, and the "perfect" narrative will invite contrarian takes. That is a cycle, not a curse.

Third: the release calendar tells its own tale — Telluride premiere, October US opening, November UK rollout is a classic awards-season launch pattern. The acclaim is verifiable (two independent aggregators), so this is no bubble; but the narrative is clearly built to run through awards season.

And what I want most to remember: this film's subject is in prison. The patients who received faulty blood-test results have no headline. As a documentary maker I know every project carries a page marked "do not fill". The true emptiness of this story lives on that page: the voices of the people whose blood was tested.

I write football not as a result, but as a room full of unspoken things. The Theranos story is such a room. Nine billion dollars, eleven years, one hundred percent — the silence between those three numbers is what the film is measuring, and what we should measure too.

After the UK release on November 20, the question will remain: those who placed money and trust in a technology proven not to work — will we, on this side of the screen, finally listen to them, or will we once again just read the scoreboard?

The whistle blows. The story keeps breathing.